von Ebner's glands intercalated duct adenocarcinoma with PALB2 gene mutation

Ameer Hamza, Renata Ferrarotto, Diana Kaya, Randal S. Weber, Diana Bell

Research output: Contribution to journalArticlepeer-review

Abstract

Secretory carcinoma of the salivary glands is a distinct entity with distinct morphologic features, immunohistochemical profile and molecular alterations. It mainly affects middle aged individuals with slight male predominance and parotid gland is the most common site of involvement. Although ETV6-NTRK3 gene fusion is considered pathognomonic for secretory carcinoma, advances in molecular profiling of this tumor have led to the discovery of novel ETV6 fusion partners and gene mutations. Herein, we describe a case of an adenocarcinoma of intercalated duct origin favor secretory carcinoma, in a unique location of von Ebner's glands of mobile tongue in a 40-year-old Caucasian female. Aside from being in a unique location, the tumor showed somatic mutation for PALB2 gene which has not been described so far in secretory carcinoma. Discovery of novel fusions and mutations have therapeutic implications with respect to targeted therapy.

Original languageEnglish (US)
Article number151637
JournalAnnals of Diagnostic Pathology
Volume49
DOIs
StatePublished - Dec 2020

Keywords

  • Adenocarcinoma
  • Intercalated duct
  • Secretory
  • Targeted therapy
  • von Ebner's glands, PALB2 gene

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint

Dive into the research topics of 'von Ebner's glands intercalated duct adenocarcinoma with PALB2 gene mutation'. Together they form a unique fingerprint.

Cite this